1. Home
  2. PEN vs ATR Comparison

PEN vs ATR Comparison

Compare PEN & ATR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • ATR
  • Stock Information
  • Founded
  • PEN 2004
  • ATR 1992
  • Country
  • PEN United States
  • ATR United States
  • Employees
  • PEN N/A
  • ATR N/A
  • Industry
  • PEN Medical/Dental Instruments
  • ATR Plastic Products
  • Sector
  • PEN Health Care
  • ATR Industrials
  • Exchange
  • PEN Nasdaq
  • ATR Nasdaq
  • Market Cap
  • PEN 10.1B
  • ATR 10.2B
  • IPO Year
  • PEN 2015
  • ATR 1993
  • Fundamental
  • Price
  • PEN $238.44
  • ATR $157.89
  • Analyst Decision
  • PEN Strong Buy
  • ATR Strong Buy
  • Analyst Count
  • PEN 16
  • ATR 4
  • Target Price
  • PEN $302.40
  • ATR $180.00
  • AVG Volume (30 Days)
  • PEN 404.1K
  • ATR 352.3K
  • Earning Date
  • PEN 07-29-2025
  • ATR 07-31-2025
  • Dividend Yield
  • PEN N/A
  • ATR 1.14%
  • EPS Growth
  • PEN N/A
  • ATR 17.39
  • EPS
  • PEN 1.08
  • ATR 5.47
  • Revenue
  • PEN $1,240,100,000.00
  • ATR $3,554,747,000.00
  • Revenue This Year
  • PEN $14.60
  • ATR $4.27
  • Revenue Next Year
  • PEN $14.24
  • ATR $5.25
  • P/E Ratio
  • PEN $221.29
  • ATR $28.76
  • Revenue Growth
  • PEN 13.17
  • ATR 0.34
  • 52 Week Low
  • PEN $148.00
  • ATR $130.85
  • 52 Week High
  • PEN $310.00
  • ATR $178.03
  • Technical
  • Relative Strength Index (RSI)
  • PEN 26.12
  • ATR 55.94
  • Support Level
  • PEN $240.12
  • ATR $158.10
  • Resistance Level
  • PEN $253.94
  • ATR $160.36
  • Average True Range (ATR)
  • PEN 5.78
  • ATR 2.22
  • MACD
  • PEN -0.66
  • ATR 0.27
  • Stochastic Oscillator
  • PEN 10.05
  • ATR 64.17

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About ATR AptarGroup Inc.

Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.

Share on Social Networks: